April-June, Volume 6, Number
The new issue of Px Wire highlights the adherence issues raised, again, by the recent VOICE trial results and explores changes being implemented by trial sponsors and researchers working to improve trial and real-world adherence to new HIV prevention options.
In addition, we introduce a new tool created to help civil society influence PEFPAR annual Country Operational Plans (COPs), which describe national PEPFAR targets, goals, implementing partners and budgets. We also look at the new funding model for the Global Fund.
Our centerspread showcases the ARV-based HIV prevention pipeline from pre-clinical research to implementation projects. More graphics are available below, including charts on the efficacy and adherence of PrEP trials and a list of ongoing and planned demonstration projects.
Download the centerspread and additional graphics from the latest issue of Px Wire:
- ARV-Based Prevention Research and
Development Product Pipeline (PDF),
- Ongoing and Planned PrEP Trials and Demonstration Projects (PDF), (JPEG)
- PrEP Trials Efficacy and Adherence (PDF), (JPEG)
Px Wire Archive: View Px Wire issues starting from January 2008